In Silico Rational Design of Novel 1,3,4‐Oxadiazole Thioether Derivatives for the Discovery of Xanthomonas oryzae Inhibitors
Chemistry & Biodiversity · 2026-07 · 23 (7)
DOI: 10.1002/cbdv.71481 ↗At a glance
Journal article in Chemistry & Biodiversity, published online on 2026-07-14. Written by Jie Zhong and 6 co-authors. Institution: Department of Chemistry, University of Shanghai for Science and Technology, Shanghai, P. R. China. Major MEDLINE topics: Oxadiazoles, Xanthomonas, Drug Design, Anti-Bacterial Agents. 41 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Jing Chu University of Technology.
Abstract (original language)
A series of newly designed 1,3,4‐oxadiazole derivatives demonstrated highly effective inhibitors against Xanthomonas oryzae pv. oryzae ( Xoo ) and exhibited significant antiviral and anti‐biofilm properties. To further explore the structure‐activity relationships of these compounds and develop novel molecules with higher activity, this study systematically analyzed the relationship between the structure and activity of a series of 1,3,4‐oxadiazole compounds using computational methods including 3D‐QSAR, molecular docking, and molecular dynamics simulations. Based on a dataset containing 39 compounds, two reliable 3D‐QSAR statistical models were established: CoMFA ( q 2 = 0.729, SEE = 0.075, r 2 = 0.960, F = 103.183) and CoMSIA/ADH ( q 2 = 0.805, SEE = 0.059, r 2 = 0.978, F = 157.574). A 3D contour plot analysis revealed key structural factors influencing molecular activity. Molecular docking studies explored the interaction mode between the small molecule and the target protein 3E5U, identifying important residues such as ARG300. Based on model predictions and results comparison, we designed eight new molecules with inhibitory activity superior to the template compound. Molecular dynamics simulations further confirmed the stability of the binding between new molecules and protein complex. Pharmacokinetic evaluation indicated that these new molecules have promising clinical application prospects.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, University of Shanghai for Science and Technology, Shanghai, P. R. China.
- School of Chemical and Environmental Engineering, Shanghai Institute of Technology, Shanghai, P. R. China.
ORCID profiles: Fei Xiong
Funding
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Jing Chu University of Technology
Cite
APA
Zhong, J., Jiang, H., Zhan, J., Zhang, Z., Chen, J., Wang, Z., & Xiong, F. (2026). In Silico Rational Design of Novel 1,3,4‐Oxadiazole Thioether Derivatives for the Discovery of Xanthomonas oryzae Inhibitors. Chemistry & Biodiversity, 23(7). https://doi.org/10.1002/cbdv.71481
Vancouver
Zhong J, Jiang H, Zhan J, Zhang Z, Chen J, Wang Z, et al. In Silico Rational Design of Novel 1,3,4‐Oxadiazole Thioether Derivatives for the Discovery of Xanthomonas oryzae Inhibitors. Chemistry & Biodiversity. 2026;23(7). doi:10.1002/cbdv.71481
BibTeX
@article{Zhong2026,
author = {Zhong, Jie and Jiang, Huiying and Zhan, Junjie and Zhang, Zhenyu and Chen, Jiawei and Wang, Zhonghua and Xiong, Fei},
title = {In Silico Rational Design of Novel 1,3,4‐Oxadiazole Thioether Derivatives for the Discovery of Xanthomonas oryzae Inhibitors},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {7},
doi = {10.1002/cbdv.71481}
}
EUVIMED